Cargando…
Adherence to Monitoring Guidelines of Amiodarone Adverse Reactions
BACKGROUND: Amiodarone treatment frequently causes adverse reactions. Clinical guidelines warrant a comprehensive assessment prior to chronic treatment with amiodarone and repeated monitoring for the appearance of adverse reactions. OBJECTIVE: To evaluate adherence to these guidelines. METHODS: A re...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472159/ https://www.ncbi.nlm.nih.gov/pubmed/31024983 http://dx.doi.org/10.1177/2333392819844635 |
_version_ | 1783412189527277568 |
---|---|
author | Lavon, Ophir Goldman, Ron |
author_facet | Lavon, Ophir Goldman, Ron |
author_sort | Lavon, Ophir |
collection | PubMed |
description | BACKGROUND: Amiodarone treatment frequently causes adverse reactions. Clinical guidelines warrant a comprehensive assessment prior to chronic treatment with amiodarone and repeated monitoring for the appearance of adverse reactions. OBJECTIVE: To evaluate adherence to these guidelines. METHODS: A retrospective chart review of electronic medical records of adult patients treated with oral amiodarone for at least 12 months. RESULTS: One hundred patient records were analyzed; 97% of patients were evaluated for thyroid and liver functions prior to treatment. Liver functions were properly monitored every 6 months in 96% of patients and thyroid function in only 59%. Most (84%) patients completed a chest X-ray before treatment; only 2% completed a respiratory function test. None have performed a chest X-ray annually. Sixty-four percent of the patients were examined by an ophthalmologist prior to treatment; periodic ophthalmic surveillance was not consistent. Neurological and dermatological evaluations were not recorded for any of the patients, unless symptoms appeared. Only 50% were adherent to annual cardiac reassessment. CONCLUSIONS: Adherence to recommended clinical guidelines for monitoring amiodarone adverse reactions is poor. Interventions to improve compliance with these guidelines are needed. |
format | Online Article Text |
id | pubmed-6472159 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-64721592019-04-25 Adherence to Monitoring Guidelines of Amiodarone Adverse Reactions Lavon, Ophir Goldman, Ron Health Serv Res Manag Epidemiol Original Research BACKGROUND: Amiodarone treatment frequently causes adverse reactions. Clinical guidelines warrant a comprehensive assessment prior to chronic treatment with amiodarone and repeated monitoring for the appearance of adverse reactions. OBJECTIVE: To evaluate adherence to these guidelines. METHODS: A retrospective chart review of electronic medical records of adult patients treated with oral amiodarone for at least 12 months. RESULTS: One hundred patient records were analyzed; 97% of patients were evaluated for thyroid and liver functions prior to treatment. Liver functions were properly monitored every 6 months in 96% of patients and thyroid function in only 59%. Most (84%) patients completed a chest X-ray before treatment; only 2% completed a respiratory function test. None have performed a chest X-ray annually. Sixty-four percent of the patients were examined by an ophthalmologist prior to treatment; periodic ophthalmic surveillance was not consistent. Neurological and dermatological evaluations were not recorded for any of the patients, unless symptoms appeared. Only 50% were adherent to annual cardiac reassessment. CONCLUSIONS: Adherence to recommended clinical guidelines for monitoring amiodarone adverse reactions is poor. Interventions to improve compliance with these guidelines are needed. SAGE Publications 2019-04-16 /pmc/articles/PMC6472159/ /pubmed/31024983 http://dx.doi.org/10.1177/2333392819844635 Text en © The Author(s) 2019 http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Research Lavon, Ophir Goldman, Ron Adherence to Monitoring Guidelines of Amiodarone Adverse Reactions |
title | Adherence to Monitoring Guidelines of Amiodarone Adverse
Reactions |
title_full | Adherence to Monitoring Guidelines of Amiodarone Adverse
Reactions |
title_fullStr | Adherence to Monitoring Guidelines of Amiodarone Adverse
Reactions |
title_full_unstemmed | Adherence to Monitoring Guidelines of Amiodarone Adverse
Reactions |
title_short | Adherence to Monitoring Guidelines of Amiodarone Adverse
Reactions |
title_sort | adherence to monitoring guidelines of amiodarone adverse
reactions |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472159/ https://www.ncbi.nlm.nih.gov/pubmed/31024983 http://dx.doi.org/10.1177/2333392819844635 |
work_keys_str_mv | AT lavonophir adherencetomonitoringguidelinesofamiodaroneadversereactions AT goldmanron adherencetomonitoringguidelinesofamiodaroneadversereactions |